Sodium fluoride
Brand names: Duraphat, FluoriGard
Sodium fluoride is a fluoride preparation, available as toothpaste, mouthwash, tablets and varnish, used to prevent dental caries.
Adult dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substance or to any of the excipients
- Use by children aged under ten years
Side effects
- Immune system disorders — hypersensitivity reactions: rare (>1/10,000, <1/1,000)
Interactions
- §4.5: no interaction studies have been performed
Clinical monograph
How it works
Fluoride is incorporated into tooth enamel as fluorapatite, increasing resistance to acid demineralisation and promoting remineralisation, and it also inhibits oral bacterial metabolism.
Prescribing in practice
- Excessive fluoride intake, particularly in young children, causes dental fluorosis, so the local water fluoride concentration and total fluoride exposure must be considered before prescribing supplements.
- Acute overdose is toxic; keep products out of reach of children and supervise paediatric use.
- Tailor the formulation and strength to caries risk and age, following dental and a children's formulary guidance for younger patients.
Monitoring
Periodic dental review assesses caries risk and any signs of fluorosis, with attention to total fluoride exposure including water supply.
Counselling the patient
- Spit out toothpaste and avoid rinsing immediately afterwards to retain fluoride benefit.
- Supervise children's use and store products safely out of their reach.
Evidence & guidelines
The caries-preventive efficacy of topical and systemic fluoride is well established and underpins NICE and public health dental health guidance.
Reference: NICE NG30; SDCEP; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023